Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID‐19 pneumonia

202153 citationsJournal Articlegreen Open Access

Authors

M. Cazzaniga · Alessandro Manzoni Hospital

Luca Fumagalli · Alessandro Manzoni Hospital

L. D’Angelo · Alessandro Manzoni Hospital

Mario Cerino · Alessandro Manzoni Hospital

Giulia Bonfanti · University of Milan

Riccardo M. Fumagalli · University of Insubria

Gianpaolo Schiavo ·

Abstract

Absolute eosinopenia is associated with clinical outcomes in patients with COVID-19 pneumonia and might be used as a marker to discriminate patients with unfavourable prognosis.

Topics & Keywords

COVID-19 Clinical Research Studies Long-Term Effects of COVID-19 Thermal Regulation in Medicine

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: International Journal of Clinical Practice

Volume 75, Issue 7, pp. e14047-e14047

DOI: 10.1111/ijcp.14047

Field-Weighted Citation Impact: 2.80